BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8004810)

  • 1. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
    Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein.
    Kemp M; Kurtzhals JA; Christensen CB; Kharazmi A; Jardim A; Bendtzen K; Gachihi GS; Olafson RW; Theander TG
    Immunol Lett; 1993 Oct; 38(2):137-44. PubMed ID: 8294141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.
    Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
    Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
    Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.
    Kemp K; Kemp M; Kharazmi A; Ismail A; Kurtzhals JA; Hviid L; Theander TG
    Clin Exp Immunol; 1999 Jun; 116(3):500-4. PubMed ID: 10361241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
    Bhowmick S; Ravindran R; Ali N
    Infect Immun; 2008 Mar; 76(3):1003-15. PubMed ID: 18195029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
    Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
    Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cell responses to gp63, a surface antigen of Leishmania.
    Russo DM; Burns JM; Carvalho EM; Armitage RJ; Grabstein KH; Button LL; McMaster WR; Reed SG
    J Immunol; 1991 Nov; 147(10):3575-80. PubMed ID: 1940356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human T lymphocytes by Leishmania lipophosphoglycan.
    Kemp M; Theander TG; Handman E; Hey AS; Kurtzhals JA; Hviid L; Sørensen AL; Were JO; Koech DK; Kharazmi A
    Scand J Immunol; 1991 Feb; 33(2):219-24. PubMed ID: 1902000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins?
    Mendonça SC; De-Luca PM; Olafson RW; Jardim A; Coutinho SG
    Braz J Med Biol Res; 1994 Feb; 27(2):553-7. PubMed ID: 8081281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
    Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
    APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections.
    Gaafar A; Kharazmi A; Ismail A; Kemp M; Hey A; Christensen CB; Dafalla M; el Kadaro AY; el Hassan AM; Theander TG
    Clin Exp Immunol; 1995 May; 100(2):239-45. PubMed ID: 7743662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.
    Ghosh A; Zhang WW; Matlashewski G
    Vaccine; 2001 Oct; 20(1-2):59-66. PubMed ID: 11567746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
    Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.